🇺🇸 FDA
Pipeline program

Azvudine

IBR2022072

Unknown small_molecule active

Quick answer

Azvudine for SARS-CoV-2 Infection is a Unknown program (small_molecule) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
SARS-CoV-2 Infection
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials